The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 811-817

  Duong, F ^a   Fournier, J ^b   Keane, P E ^b   Guenet J L ^c   Soubrie P ^b   Warter, J M ^a   Borg, J ^a   Poindron, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b SANOFI   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Motor neurone disease; Neuroprotection; Neurotrophic effect; pmn mouse; SR 57746A

Indexed keywords

1 (2BETA NAPHTHYLETHYL) 4 (3 TRIFLUOROMETHYLPHENYL) 1,2,5,6 TETRAHYDROPYRIDINE HYDROCHLORIDE; NEUROTROPHIC FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; GASTROCNEMIUS MUSCLE; MOTOR NEUROPATHY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ELECTROPHYSIOLOGY; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; MOTOR NEURON DISEASE; MOTOR NEURONS; MUSCLE, SKELETAL; NAPHTHALENES; NERVE DEGENERATION; NERVE FIBERS; NEUROPROTECTIVE AGENTS; PYRIDINES; SCIATIC NERVE; TIME FACTORS;

EID: 0031862112     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701885     Document Type: Article

References (22)

1. ARENAS, E. & PERSSON, H. (1994). Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature, 367, 368-371.
2. ARENAS, E., TRUPP, M., AKERUD, P. & IBANEZ, C.F. (1995). GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 15, 1465-1473.
3. BRAUN, S., CROIZAT, B., LAGRANGE, M.C., WARTER, J.M. & POINDRON, P. (1996). Neurotrophins increase motoneurons' ability to innervate skeletal muscle fibers in rat spinal cord-human muscle cocultures. J. Neurol. Sci., 136, 17-23.
4. DIMITRU, D. & DELISA, J.A. (1991). AAEM minimonograph #10: Volume conduction. Muscle nerve, 14, 605-624.
5. FOURNIER, J., GAUTHIER, T., KEANE, P.E., COUDÉ, F.X., GUZZI, U., SOUBRIÉ, P. & LE FUR, G. (1992). Neurotrophic effects of SR 57746A, a new non-peptide compound: in vitro studies. Br. J. Pharmacol., 106, 120P.
6. FOURNIER, J., KEANE, P.E., FERRARA, P. & SOUBRIÉ, P. (1997). SR 57746A: an orally active non-peptide compound with neurotrophic and neuroprotective effects. CNS Drug Rev., 3, 148-167.
7. FOURNIER, J., STEINBERG, R., GAUTHIER, T., KEANE, P.E., GUZZI, U., COUDÉ, F.X., BOUGAULT, I., MAFFRAND, J.P., SOUBRIÈ, P. & LE FUR, G. (1993). Neuroprotective effects of SR 57746A in central and peripheral models in rodents and primates. Neuroscience, 55, 629-641.
8. HAASE, G., KENNEL, P., PETTMANN, B., VIGNE, E., AKLI, S., REVAH, F., SCHMALBRUCH, H. & KAHN, A. (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med., 3, 429-436.
9. HEFTI, F. (1994). Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol., 25, 1418-1435.
10. HUGHES, R.A., SENDTNER, M. & THOENEN, H. (1993). Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neuronsci. Res., 36, 663-671.
11. KEANE, P.E., FOURNIER, J., STEINBERG, R. GAUTHIER, T., COUDÉ, F.X., GUZZI, U., SOUBRIÈ, P. & LE FUR, G. (1992). Neurotrophic effects of SR 57746A in a variety of neurodegenerative models in vivo. Br. J. Pharmacol., 106, 52P.
12. KENNEL, P.F., FONTENEAU, P., MARTIN, E., SCHMIDT, J.M., AZZOUZ, M., BORG, J., GUÉNET, J.L., SCHMALBRUCH, H., WARTER, J.M. & POINDRON, P. (1996). Electromyographical and motor performance studies in the pmn model of neurodegenerative disease. Neurobiol. Disease, 3, 137-147.
13. LABIE, C., LAFON, C., FOURNIER, J., KEANE, P., LE FUR, G., MAFFRAND, J.P. & SOUBRIÉ, P. (1998). Effect of the non-peptide neuroprotective compound SR 57746A on NGF and BDNF synthesis in primary astrocytes in culture. Br. J. Pharmacol., (in press).
14. LACOMBLEZ, L., DOPPLER, V., BENSIMON, G., SALACHAS, F., DOUILLET, P., BOUCHE, P., DEROUESNE, C. & MEININGER, V. (1996). Safety and efficacy controlled trial of SR 57746A in amyotrophic lateral sclerosis. Meth. Find. Exp. Clin. Pharmacol., 18, Suppl B, 206.
15. PRADINES, A., MAGAZIN, M., SCHILTZ, P., LE FUR, G., CAPUT, D. & FERRARA, P. (1995). Evidence for nerve growth factor-potentiating activities of the nonpeptidic compound SR 57746A in PC12 cells. J. Neurochem., 64, 1954-1964.
16. RUIGT, G.S.F., MAKKINK, W.K. & KONINGS, P.N.M. (1996). SR 57746A attenuates cytostatic drug-induced reduction of neurite outgrowth in co-cultures of rat dorsal root ganglia and Schwann cells. Neurosci. Lett., 203, 9-12.
17. SAGOT, Y., DUBOIS-DAUPHIN, M., TAN, S.A., DE BILBAO, F., AEBISCHER, P., MARTINOU, J.C. & KATO, A.C. (1995). Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci., 15, 7727-7733.
18. SAGOT, Y., TAN, S.A., HAMMANG. J.P., AEBISCHER, P. & KATO, A.C. (1996). GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci., 16, 2335-2341.
19. SCHMALBRUCH, H., SKOVGAARD JENSEN, H.J., BJAERG, M., KAMIENIECKA, Z. & KURLAND, L. (1991). A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol., 50, 192-204.
20. SENDTNER, M., KREUTZBERG, G.W. & THOENEN, H. (1990). Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature, 345, 440-441.
21. SENDTNER, M., HOLTMANN, B. & HUGHES, R.A. (1996). The response of motoneurons to neurotrophins. Neurochem. Res., 21, 831-841.
22. SENDTNER, M., SCHMALBRUCH, H., STOCKLI, K.A., CARROLL, P., KREUTZBERG, G.W. & THOENEN, H. (1992). Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature, 35, 502-504.